FDA approves Minima heart stent for infants and young children with congenital heart defects.

The FDA has approved the Minima heart stent for infants and young children, designed to treat congenital heart defects and reduce the need for multiple open-heart surgeries. Annually, about 40,000 U.S. babies are born with such defects. Unlike traditional stents, the Minima stent grows with the child and can be adjusted through a minimally invasive procedure, allowing for shorter hospital stays—typically just one day compared to a week for surgery.

October 17, 2024
10 Articles

Further Reading